Abstract
The guiding principle behind efforts to develop DNA sequence-specific agents is that greater biological response may be achieved for a given dose compared with a sequence-neutral agent, thereby reducing toxic side-effects. A related goal is the selective suppression of transcription from particular gene sequences (Stephenson and Zamecnik, 1978; Izant and Weintraub, 1984).
Preview
Unable to display preview. Download preview PDF.
References
Bailly, C., Catteau, J.-P., Henichart, J.-P., Reszka, K., Shea, R. G., Krowicki, K. and Lown, J. W. (1989). Subcellular distribution of a nitroxide spin-labeled netropsin in living KB cells: E.P.R. and sequence specificity studies. Biochem. Pharmacol., 38, 1625–1630
Dickerson, R. E. (1983a). The DNA helix and how it is read. Scientific American, 249, 94–111
Dickerson, R. E. (1983b). Base sequence, helix structure and intrinsic information readout. In Pullman, B. and Jortner, J. (Eds), Nucleic Acids: The Vectors of Life. D. Reidel, Jerusalem, pp. 1–15
Dervan, P. B. (1986). Design of sequence-specific DNA-binding molecules. Science, 232, 464–471
Goodsell, D. and Dickerson, R. E. (1986). Isohelical analysis of DNA groove-binding drugs. J. Med. Chem., 29, 727–733
Hélène, C. (1987). Lecture on antisense probes in the International Symposium on DNA as a Target for Chemotherapeutic Action, Seillac, France, October 11–17
Hélène, C., Montenay-Garestier, T., Saison, T., Takasugi, M., Toulme, J. J., Asseline, U., Lancelot, G., Maurizot, J. C., Toulmé, F. and Thuong, N. T. (1985). Oligodeoxynucleotides covalently linked to intercalating agents: A new class of gene regulatory substances. Biochimie, 67, 777–783
Holt, J. T., Venkat, G. T., Moulton, A. D. and Nienhuis, A. W. (1986). Inducible production of c-fos antisense RNA inhibits 3T3 cell proliferation. Proc. Natl Acad. Sci. USA, 83, 4794–4798
Hurley, L.-H., Reck, T., Thurston, D. E., Langley, D. R., Holden, K. G., Hertzberg, R. P., Hoover, J. R. E., Gallagher, G., Fancette, L. F., Mong, S. M. and Johnson, R. K. (1988). Pyrrolo-[1,4]-benzodiazepine antitumor antibiotics: Relationship of DNA alkylation and sequence specificity to the biological activity of natural and synthetic compounds. Chem. Res. Toxicol., 1, 258–268
Izant, J. G. and Weintraub, H. (1984) Inhibition of thymidine kinase gene expression by antisense RNA: A molecular approach to genetic analysis. Cell, 36, 1007–1015
Kissinger, K. L., Dabrowiak, J.-C. and Lown, J. W. (1990). Molecular recognition between oligopeptides and nucleic acids: DNA binding specificity of a series of bis-netropsin analogues deduced from footprinting analysis. Chem. Res. Toxicol., 3, 162–168
Kissinger, K. L., Krowicki, K., Dabrowiak, J.-C. and Lown, J. W. (1987). Mono-cationic imidazole lexitropsins that display enhanced GC sequence dependent DNA binding. Biochemistry, 26, 5590–5595
Kopka, M. L., Yoon, C., Goodsell, D., Pjura, P. and Dickerson, R. E. (1985). The molecular origin of DNA-drug specificity in netropsin and distamycin. Proc. Natl Acad. Sci. USA, 82, 1376–1380
Kumar, S., Jaseja, M., Zimmermann, J., Yadigiri, B., Pon, R. T. and Lown, J. W. (1990). Molecular recognition and binding of a GC site-avoiding thiazolelexitropsin to d[CGCAATTGCG]Z:1H-NMR evidence for thiazole intercalation. J. Biomol. Struct. Dynam., 8, 99–121
Kumar, S., Yadagiri, B., Pon, R. T. and Lown, J. W. (1990). Sequence specific molecular recognition and binding by a Hoechst 33258 analog to the decadeoxyribonucleotide d[CATGGCCATG]2: Structural and dynamic aspects deduced from high field 1H-NMR studies. J. Biomol. Struct. Dynam., 8, 331–357
Lee, M., Coulter, D. M. and Lown, J. W. (1988a). Total synthesis and absolute configuration of the antibiotic oligopeptide (4S)(+) anthelvencin A and its (4R)(-) enantiomer. J. Org. Chem., 53, 1855–1859
Lee, M. D., Dunne, T. S., Chang, C. C., Ellestad, G. A., Siegel, M. M., Morton, G. O., McGahren, W. J. and Borders, D. B. (1987). Calichemicins, a novel family of antitumor antibiotics. Chemistry and structure of calcichemicin ϒ1. J. Am. Chem. Soc., 109, 3466–3468
Lee, M., Krowicki, K., Hartley, J. A., Pon, R. T. and Lown, J. W. (1988b). Molecular recognition between oligopeptides and nucleic acids: Influence of van der Waals contacts in determining the 3’-terminus of DNA sequences read by monocationic lexitropsins. J. Am. Chem. Soc., 110, 3641–3649
Lee, M., Krowicki, K., Shea, R. G., Pon, R. T. and Lown, J. W. (1989a). Molecular recognition between oligopeptides and nucleic acids: Specificity of binding of a monocationic bis-furan lexitropsin to DNA deduced from footprinting and 1H-NMR studies. J. Molec. Recognition, 2, 84–93
Lee, M. and Lown, J. W. (1987). Synthesis of (4S) and (4R)-methyl-2-amino-lpyrroline-5-carboxylates and their application to the preparation of (4S)(+) and (4R)(-) dihydrokikumycin. J. Org. Chem., 52, 5717–5721
Lee, M., Shea, R. G., Hartley, J. A., Kissinger, K., Pon, R. T., Vesnaver, G., Breslauer, K. J., Dabrowiak, J.-C. and Lown, J. W. (1989b). Molecular recognition between oligopeptides and nucleic acids: Sequence specific binding of the naturally occurring antibiotic (4S)(+) anthelvencin A and its (4R)(-) enantiomer to DNA deduced from 1H-NMR, footprinting and thermodynamic data. J. Am. Chem Soc., 111, 345–354
Lee, M., Shea, R. G., Hartley, J. A., Lown, J. W., Kissinger, K., Dabrowiak, J.-C., Vesnaver, G., Breslauer, K. J. and Pon, R. T. (1989c). Molecular recognition between oligopeptides and nucleic acids: Sequence specific binding of (4S)(+) and (4R)(-)-dihydrokikumycin B to DNA deduced from 1H-NMR, footprinting studies and thermodynamic data. J. Molec. Recognition, 2, 6–17
Lin, S. Y. and Grollman, A. P. (1981). Interactions of a fragment of bleomycin with deoxyribodinucleotides: Nuclear magnetic resonance studies. Biochemistry, 20, 7589–7598
Lown, J. W. (1988). Lexitropsins: Rational design of DNA sequence reading agents as novel anti-cancer agents and potential cellular probes. Anti-cancer Drug Design, 3, 25–40
Lown, J. W. (1989). Synthetic chemistry of naturally occurring oligopeptide antibiotics and related lexitropsins. Org. Prep. Proced. Int., 21 (1), 1–46
Lown, J. W. and Beerman, T. A. (1990). Unpublished results
Lown, J. W., Krowicki, K., Balzarini, J., Newman, R. A. and De Clercq, E. (1989). Novel linked antiviral and antitumor agents related to netropsin and distamycin: Synthesis and biological evaluation. J. Med. Chem., 32, 2368–2375
Maher, L. J., Wold, B. and Dervan, P. B. (1989). Inhibition of DNA binding proteins by oligonucleotide-directed triple helix formation. Science, 245, 725–730
Miller, P. S., Agris, C. H., Aurehani, L., Blake, K. R., Murakami, A., Reddy, M. P., Spitz, S. A. and Ts’o, P. O. P. (1986). Control of ribonucleic acid function by oligonucleoside methyl phosphonates. Biochimie, 67, 769–776
Osawa, E. and Musso, H. (1982). Application of molecular mechanics calculations in organic chemistry. In Allinger, N. L., Elie!, E. L. and Wilen, S. H. (Eds), Topics in Stereochemistry. Wiley, New York, p. 117
Pjura, P. E., Grzeskowiak, K. and Dickerson, R. E. (1989). Binding of Hoechst 33258 to the minor groove of DNA. J. Mol. Biol., 147, 257–271
Rao, K. E., Bathini, Y. and Lown, J. W. (1990a). Synthesis of novel thiazole containing DNA minor groove binding oligopeptides related to the antibiotic distamycin. J. Org. Chem., 55, 728–737
Rao, K. E., Krowicki, K., Balzarini, J., De Clercq, E., Newman, R. A. and Lown, J. W. (1991). Novel linked antiviral and antitumor agents related to netropsin. 2: Synthesis and biological evaluation. Actualities de Chimie Therapeutique, 18 series, 21–41
Rao, K. E. and Lown, J. W. (1990). Mode of action of saframycin antitumor antibiotics: Sequence selectivities in the covalent binding of saframycins A and S to DNA. Chem. Res. Toxicol., 3, 262–267
Rao, K. E., Shea, R. G., Yadagiri, B. and Lown, J. W. (1990b). Molecular recognition between oligopeptides and nucleic acids: DNA sequence specificity and binding properties of thiazole-lexitropsins incorporating the concepts of base site acceptance and avoidance. Anti-cancer Drug Design, 5, 3–20
Rao, K. E., Zimmermann, J. and Lown, J. W. (1990c). Sequence selective DNA binding by linked bis N-methylpyrrole dipeptides: An analysis by MPE footprinting and force field calculations. J. Org. Chem., 56, 786–797
Reynolds, V. L., Molineux, L. J., Kaplan, D., Swenson, D. H. and Hurley, L. H. (1985). Reaction of the antitumor antibiotic CC-1065 with DNA. Location of the site of structurally induced strand breakage and analysis of DNA sequence specificity. Biochemistry, 24, 6228–6237
Stephenson, M. L. and Zamecnik, P. C. (1978). Inhibition of Rous sarcoma viral RNA translation by a specific oligodeoxyribonucleotide. Proc. Natl Acad. Sci. USA, 75, 285–288
Stubbe, J. and Kozarich, J. W. (1987). Mechanisms of bleomycin-induced DNA degradation. Chem. Rev., 87, 1107–1136
Ward, B., Rehfuss, R. and Dabrowiak, J. C. (1987). Quantitative footprinting analysis of the netropsin-DNA interaction. J. Biomol. Struct. Dyn., 4, 685–695
Warpehoski, M. A. and Hurley, L. H. (1988). Sequence selectivity of DNA covalent modification. Chem. Res. Toxicol., 1, 315–333
Wilson. W. D., Tanious, F. A., Barton, H. J., Strekowski, L., Boykin, D. W. and Jones, R. L. (1989). Binding of 4’,6-diamidino-2-phenylindole (DAPI) to GC and mixed sequences in DNA: Intercalation of a classical groove-binding molecule. J. Am. Chem. Soc., 111, 5008–5010
Woynarowski, J. M., Sigmund, R. D. and Beerman, T. A. (1989). DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells. Biochemistry, 28, 3850–3855
Youngquist, R. S. and Dervan, P. B. (1985). Sequence specific recognition of B-DNA by oligo(N-methylpyrrolecarboxamide). Proc. Natl Acad. Sci. USA, 82, 2565–2569
Zimmer, C. and Wahnert, U. (1986). Non-intercalating DNA-binding ligands: Specificity of the interaction and their use as tools in biophysical, biochemical and biological investigations of the genetic material. Prog. Biophys. Mol. Biol., 47, 31–112
Editor information
Editors and Affiliations
Copyright information
© 1993 The contributors
About this chapter
Cite this chapter
Lown, J.W. (1993). Design of Sequence-specific Agents: Lexitropsins. In: Neidle, S., Waring, M.J. (eds) Molecular Aspects of Anticancer Drug-DNA Interactions. Topics in Molecular and Structural Biology. Palgrave, London. https://doi.org/10.1007/978-1-349-12356-8_11
Download citation
DOI: https://doi.org/10.1007/978-1-349-12356-8_11
Publisher Name: Palgrave, London
Print ISBN: 978-1-349-12358-2
Online ISBN: 978-1-349-12356-8
eBook Packages: EngineeringEngineering (R0)